Skip to main content

Accustem Sciences Inc.

ACUT
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001850767

No open-market purchases or sales by Accustem Sciences Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Accustem Sciences Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ACUT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders10−1
Shares300−30 (−100.0%)
Value$14$0−$14 (−100.0%)

New holders (0)

Institutions that held Accustem Sciences Inc. at the end of Q1 2025 but not at the end of Q4 2024.

None.

Sold out (1)

Institutions that held Accustem Sciences Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of ACUT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Studio Investment Management LLC30$14